The average price per milliliter of insulin increased by 197% between 2002 and 2013 to $12.92, according to a study reported today in the Journal of the American Medical Association. The authors analyzed individual and prescription-level data from the Medical Expenditure Panel Survey to compare trends in expenditure and price of anti-hyperglycemic medications in the United States from 2002 through 2013. Based on a sample of 27,878 people treated for diabetes, average annual spending for insulin per patient increased from $231 to $736 over the period.

Related News Articles

Headline
The Senate Committee on Health, Education, Labor and Pensions today held the second in a series of hearings on the cost of prescription drugs. “We…
Headline
The Senate Finance Committee today held a hearing on issues impacting health care costs and coverage. Witnesses included former Centers for Medicare &…
Headline
President Trump Friday signed into law the FDA Reauthorization Act (H.R. 2430). The bill reauthorizes and amends four FDA user fee programs under which…
Headline
The average monthly premium for a basic Medicare Part D prescription drug plan in 2018 is estimated to be $33.50 per month – or approximately $1.20 less…
Headline
The Senate yesterday voted 94-1 to approve the FDA Reauthorization Act (H.R. 2430), sending the legislation to the president for his signature. The bill…
Headline
Senate Democratic Leader Charles Schumer and House Democratic Leader Nancy Pelosi today unveiled an economic plan focused on improving wages, lowering costs…